254 related articles for article (PubMed ID: 15390060)
1. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
2. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
3. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U
Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
[No Abstract] [Full Text] [Related]
4. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y
Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
[TBL] [Abstract][Full Text] [Related]
6. Predictors of sudden onset of sleep in Parkinson's disease.
Körner Y; Meindorfner C; Möller JC; Stiasny-Kolster K; Haja D; Cassel W; Oertel WH; Krüger HP
Mov Disord; 2004 Nov; 19(11):1298-305. PubMed ID: 15389999
[TBL] [Abstract][Full Text] [Related]
7. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
Paus S; Grünewald A; Klein C; Knapp M; Zimprich A; Janetzky B; Möller JC; Klockgether T; Wüllner U
Mov Disord; 2008 Mar; 23(4):599-602. PubMed ID: 18175338
[TBL] [Abstract][Full Text] [Related]
8. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
Möller JC; Stiasny K; Hargutt V; Cassel W; Tietze H; Peter JH; Krüger HP; Oertel WH
Mov Disord; 2002 May; 17(3):474-81. PubMed ID: 12112193
[TBL] [Abstract][Full Text] [Related]
10. Excessive daytime sleepiness in parkinsonism.
Arnulf I
Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
[TBL] [Abstract][Full Text] [Related]
12. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
Strong JA; Dalvi A; Revilla FJ; Sahay A; Samaha FJ; Welge JA; Gong J; Gartner M; Yue X; Yu L
Mov Disord; 2006 May; 21(5):654-9. PubMed ID: 16435402
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population.
Leszczyńska-Rodziewicz A; Hauser J; Dmitrzak-Weglarz M; Skibińka M; Czerski P; Zakrzewska A; Kosmowska M; Rybakowski JK
Med Sci Monit; 2005 Jun; 11(6):CR289-295. PubMed ID: 15917720
[TBL] [Abstract][Full Text] [Related]
14. Sudden uncontrollable somnolence and medication use in Parkinson disease.
Avorn J; Schneeweiss S; Sudarsky LR; Benner J; Kiyota Y; Levin R; Glynn RJ
Arch Neurol; 2005 Aug; 62(8):1242-8. PubMed ID: 16087765
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D4 receptor polymorphism and idiopathic Parkinson's disease.
Kronenberg MF; Menzel HJ; Ebersbach G; Wenning GK; Luginger E; Gollner M; Ransmayr G; Utermann G; Poewe W; Kronenberg F
Eur J Hum Genet; 1999 Apr; 7(3):397-400. PubMed ID: 10234518
[TBL] [Abstract][Full Text] [Related]
16. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.
Makoff AJ; Graham JM; Arranz MJ; Forsyth J; Li T; Aitchison KJ; Shaikh S; Grünewald RA
Pharmacogenetics; 2000 Feb; 10(1):43-8. PubMed ID: 10739171
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
[TBL] [Abstract][Full Text] [Related]
18. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany.
Lücking CB; Lichtner P; Kramer ER; Gieger C; Illig T; Dichgans M; Berg D; Gasser T
Neurobiol Aging; 2010 Jan; 31(1):167-8. PubMed ID: 18436345
[TBL] [Abstract][Full Text] [Related]
20. Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep.
Möller JC; Rethfeldt M; Körner Y; Stiasny-Kolster K; Cassel W; Meindorfner C; Rissling I; Krüger HP; Oertel WH
Mov Disord; 2005 Dec; 20(12):1620-2. PubMed ID: 16078226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
